{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:07:50Z","timestamp":1770890870054,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0042\/0020"],"award-info":[{"award-number":["RD12\/0042\/0020"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0042\/0013"],"award-info":[{"award-number":["RD12\/0042\/0013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Behavior"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Epilepsy has been associated with cardiovascular comorbidity. This study aimed to assess the potential association between cardiovascular risk factors (<jats:styled-content style=\"fixed-case\">CRF<\/jats:styled-content>s), antiepileptic drugs (<jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s), and etiology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and Methods<\/jats:title><jats:p>A single\u2010center retrospective epilepsy cohort from the decade of 2004\u20132013 was assessed. Poisson regression models with robust variance were estimated to obtain <jats:styled-content style=\"fixed-case\">CRF<\/jats:styled-content> prevalence ratios (<jats:styled-content style=\"fixed-case\">PR<\/jats:styled-content>) according to <jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content> prescription and etiology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After excluding patients in the monotherapy group with vascular etiology or previous cardiovascular events, in the remaining 400 patients, enzyme\u2010inducer <jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s (<jats:styled-content style=\"fixed-case\">EIAED<\/jats:styled-content>s), especially phenytoin (<jats:styled-content style=\"fixed-case\">PHT<\/jats:styled-content>), were associated with higher prevalence of dyslipidemia (<jats:styled-content style=\"fixed-case\">PR<\/jats:styled-content>a 1.77, <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a0.05), compared to valproic acid. No etiology was associated with higher prevalence of any <jats:styled-content style=\"fixed-case\">CRF<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients treated with <jats:styled-content style=\"fixed-case\">EIAED<\/jats:styled-content>s, especially <jats:styled-content style=\"fixed-case\">PHT<\/jats:styled-content>, had higher prevalence of dyslipidemia.<\/jats:p><\/jats:sec>","DOI":"10.1002\/brb3.618","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T21:52:52Z","timestamp":1482270772000},"source":"Crossref","is-referenced-by-count":17,"title":["Prevalence of cardiovascular risk factors in people with epilepsy"],"prefix":"10.1002","volume":"7","author":[{"given":"Rosa Maria","family":"Vivanco\u2010Hidalgo","sequence":"first","affiliation":[{"name":"Neurovascular Research Group Fundaci\u00f3 Institut Mar d'Investigacions M\u00e8diques (FIMIM)  Barcelona Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Gomez","sequence":"additional","affiliation":[{"name":"Neurology Department Parc de Salut Mar  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antia","family":"Moreira","sequence":"additional","affiliation":[{"name":"Neurology Department Parc de Salut Mar  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"D\u00edez","sequence":"additional","affiliation":[{"name":"Neurology Department Parc de Salut Mar  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Elosua","sequence":"additional","affiliation":[{"name":"Cardiovascular Epidemiology and Genetics Research Group Fundaci\u00f3 Institut Mar d'Investigacions M\u00e8diques (FIMIM)  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Roquer","sequence":"additional","affiliation":[{"name":"Neurovascular Research Group Fundaci\u00f3 Institut Mar d'Investigacions M\u00e8diques (FIMIM)  Barcelona Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"},{"name":"Neurology Department Parc de Salut Mar  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"Barcelona Department of Statistics(2016). Last updated October 2016. Retrieved fromhttp:\/\/www.bcn.cat\/estadistica\/catala\/index.htm"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101167.2010.0252"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101167.2012.03671"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2003.10.001"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.10.013"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2005.66104.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101167.2012.03528"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJR.0b013e3281764429"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb02586.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01052.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21615"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103856"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.03.008"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.00344.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.226.2.191"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2015.03.002"},{"key":"e_1_2_7_18_1","unstructured":"World Health Organization(2015).Epilepsy. Last updated May 2015. Retrieved fromhttp:\/\/www.who.int\/mediacentre\/factsheets\/fs999\/en\/"}],"container-title":["Brain and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbrb3.618","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/brb3.618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T20:55:00Z","timestamp":1696625700000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/brb3.618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1002\/brb3.618"],"URL":"https:\/\/doi.org\/10.1002\/brb3.618","archive":["Portico"],"relation":{},"ISSN":["2162-3279","2162-3279"],"issn-type":[{"value":"2162-3279","type":"print"},{"value":"2162-3279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]},"article-number":"e00618"}}